BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2180 related articles for article (PubMed ID: 30470818)

  • 1. Turning foes to friends: targeting cancer-associated fibroblasts.
    Chen X; Song E
    Nat Rev Drug Discov; 2019 Feb; 18(2):99-115. PubMed ID: 30470818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting CAFs to overcome anticancer therapeutic resistance.
    Saw PE; Chen J; Song E
    Trends Cancer; 2022 Jul; 8(7):527-555. PubMed ID: 35331673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials.
    Zhang H; Yue X; Chen Z; Liu C; Wu W; Zhang N; Liu Z; Yang L; Jiang Q; Cheng Q; Luo P; Liu G
    Mol Cancer; 2023 Oct; 22(1):159. PubMed ID: 37784082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment.
    Bu L; Baba H; Yoshida N; Miyake K; Yasuda T; Uchihara T; Tan P; Ishimoto T
    Oncogene; 2019 Jun; 38(25):4887-4901. PubMed ID: 30816343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-associated fibroblasts: from basic science to anticancer therapy.
    Yang D; Liu J; Qian H; Zhuang Q
    Exp Mol Med; 2023 Jul; 55(7):1322-1332. PubMed ID: 37394578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer associated fibroblasts: phenotypic and functional heterogeneity.
    Patel AK; Singh S
    Front Biosci (Landmark Ed); 2020 Mar; 25(5):961-978. PubMed ID: 32114420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-associated fibroblasts: Versatile mediators in remodeling the tumor microenvironment.
    Zhang Q; Wang Y; Liu F
    Cell Signal; 2023 Mar; 103():110567. PubMed ID: 36538999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways.
    Yoshida GJ
    J Exp Clin Cancer Res; 2020 Jun; 39(1):112. PubMed ID: 32546182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diversity and Biology of Cancer-Associated Fibroblasts.
    Biffi G; Tuveson DA
    Physiol Rev; 2021 Jan; 101(1):147-176. PubMed ID: 32466724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Associated Fibroblasts: The Architects of Stroma Remodeling.
    Santi A; Kugeratski FG; Zanivan S
    Proteomics; 2018 Mar; 18(5-6):e1700167. PubMed ID: 29280568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cancer-Associated Fibroblasts: Heterogeneity and Bimodality in Oncogenesis].
    Lunina NA; Safina DR; Kostrov SV
    Mol Biol (Mosk); 2023; 57(5):739-770. PubMed ID: 37752641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment.
    Ishii G; Ochiai A; Neri S
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):186-196. PubMed ID: 26278673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
    Ravichandra A; Bhattacharjee S; Affò S
    Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A framework for advancing our understanding of cancer-associated fibroblasts.
    Sahai E; Astsaturov I; Cukierman E; DeNardo DG; Egeblad M; Evans RM; Fearon D; Greten FR; Hingorani SR; Hunter T; Hynes RO; Jain RK; Janowitz T; Jorgensen C; Kimmelman AC; Kolonin MG; Maki RG; Powers RS; Puré E; Ramirez DC; Scherz-Shouval R; Sherman MH; Stewart S; Tlsty TD; Tuveson DA; Watt FM; Weaver V; Weeraratna AT; Werb Z
    Nat Rev Cancer; 2020 Mar; 20(3):174-186. PubMed ID: 31980749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma.
    Ying F; Chan MSM; Lee TKW
    Cell Mol Gastroenterol Hepatol; 2023; 15(4):985-999. PubMed ID: 36708970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and therapeutic relevance of cancer-associated fibroblasts.
    Chen Y; McAndrews KM; Kalluri R
    Nat Rev Clin Oncol; 2021 Dec; 18(12):792-804. PubMed ID: 34489603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities.
    Caramelo B; Zagorac S; Corral S; Marqués M; Real FX
    Eur Urol Oncol; 2023 Aug; 6(4):366-375. PubMed ID: 36890105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The roles of tumor- and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas.
    Mezawa Y; Orimo A
    Cell Tissue Res; 2016 Sep; 365(3):675-89. PubMed ID: 27506216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 109.